Oncotest offer Reinnervate’s 3D cell technology to clients 08-Jan-2013 By Dan Stanton Oncology CRO, Oncotest GmbH, will incorporate a new 3D cell culture technology into its range of preclinical assay services.
Lonza to double ADC capacity to address Visp challenge 08-Jan-2013 By Gareth Macdonald Lonza plans to double ADC capacity at its facility in Visp, Switzerland by 2014 in a move that it says could create new jobs.
